Veeva Shares Slide 4.7% as Salesforce Gains Drug Customers Veeva Systems sees a 4.7% decline in share price as Salesforce attracts its pharmaceutical clients, challenging Veeva's market position.
Veeva Systems Faces Competition From Salesforce in Pharma CRM Market Veeva Systems struggles as Salesforce enters the pharmaceutical CRM market, challenging Veeva's dominance and securing major client deals.